Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
Clinical trial NCT06447779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06447779
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-13
- Primary completion
- 2025-09-01
- Enrollment
- 25000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.